Q

    Quidel Corporation (QDEL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $14.43
    -0.31 (-2.10%)

    Market Cap: $1.01B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(31/40)
    Avg Surprise
    +51.81%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.21
    Range$0.18 - $0.24
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.85+307.9%
    60d ago$0.85+307.9%
    30d ago$0.93+345.4%
    7d ago$0.87+315.1%
    Current$0.21
    Revenue Consensus
    $628M
    Range$616M - $635M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.20
    Range$0.17 - $0.23
    2 analysts
    Revenue Consensus
    $640M
    Range$615M - $654M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.20---
    Sep 26EST
    		-$0.21---
    Jun 26
    		$0.13$-0.04+425.00%Beat+8.3%
    Mar 26
    		$-0.04N/A-111.11%Miss-105.4%
    Dec 25
    		$0.46$0.42+9.52%Beat-27.0%
    Sep 25
    		$0.80$0.51+56.86%Beat-5.9%
    Jun 25
    		$0.12$0.01+1100.00%Beat+271.4%
    Mar 25
    		$0.74$0.59+25.42%Beat+68.2%
    Dec 24
    		$0.63$0.58+8.62%Beat-46.2%
    Sep 24
    		$0.85$0.32+165.63%Beat-5.6%
    Jun 24
    		$-0.07N/A+70.83%Beat-126.9%
    Mar 24
    		$0.44$0.40+10.00%Beat-75.6%
    Dec 23
    		$1.17$2.06-43.20%Miss-33.5%
    Sep 23
    		$0.90$0.56+60.71%Beat-51.4%
    Jun 23
    		$0.26$0.26+0.00%Beat-88.9%
    Mar 23
    		$1.80$1.43+25.87%Beat-84.6%
    Dec 22
    		$1.76$1.42+23.94%Beat-75.9%
    Sep 22
    		$1.85$0.69+168.12%Beat-65.5%
    Jun 22
    		$2.34$2.68-12.69%Miss+212.0%
    Mar 22
    		$11.66$9.43+23.65%Beat+166.2%
    Dec 21
    		$7.29$5.61+29.95%Beat-34.1%
    Sep 21
    		$5.36$2.30+133.04%Beat-7.3%
    Jun 21
    		$0.75$1.19-36.97%Miss-59.7%
    Mar 21
    		$4.38$4.68-6.41%Miss+259.0%
    Dec 20
    		$11.07$10.10+9.60%Beat+1007.0%
    Sep 20
    		$5.78$4.70+22.98%Beat+725.7%
    Jun 20
    		$1.86$1.09+70.64%Beat+416.7%
    Mar 20
    		$1.22$0.95+28.42%Beat+34.1%
    Dec 19
    		$1.00$0.82+21.95%Beat+25.0%
    Sep 19
    		$0.70$0.64+9.38%Beat+18.6%
    Jun 19
    		$0.36$0.37-2.70%Miss+0.0%
    Mar 19
    		$0.91$1.05-13.33%Miss-29.5%
    Dec 18
    		$0.80$0.63+26.98%Beat+247.8%
    Sep 18
    		$0.59$0.49+20.41%Beat+227.8%
    Jun 18
    		$0.36$0.27+33.33%Beat+400.0%
    Mar 18
    		$1.29$0.98+31.63%Beat+186.7%
    Dec 17
    		$0.23$0.20+15.00%Beat+483.3%
    Sep 17
    		$0.18$0.13+38.46%Beat+80.0%
    Jun 17
    		$-0.12$-0.09-33.33%Miss-
    Mar 17
    		$0.45$0.29+55.17%Beat-
    Dec 16
    		$-0.06$0.02-400.00%Miss-
    Sep 16
    		$0.10$0.09+11.11%Beat-

    Key Metrics

    Valuation
    P/E Ratio10.69EV/EBITDA22.78x
    Price/FCF-4.67xFCF Yield-21.43%
    Profitability
    Profit Margin-39.20%Operating Margin-2.09%
    ROE-45.90%ROIC3.21%
    Financial Health
    Debt/Equity1.63xInterest Coverage0.84x
    Current Ratio1.39xQuick Ratio0.76x
    Trading Statistics
    Beta0.69Avg Volume1.67M
    52-Week High$35.5852-Week Low$9.92

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.58
    SMA 20$14.80
    SMA 50$15.85
    SMA 200$19.61
    EMA 10$14.74
    EMA 20$14.97
    EMA 50$15.28
    EMA 200$18.89

    MACD

    Line: -0.32Signal: -0.38Hist: 0.06

    ADX

    ADX: 14.4+DI: 20.2-DI: 24.2

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down36.0
    PSAR$17.48

    Bollinger Bands

    Upper Band$17.28
    Lower Band$12.32
    %B Position3353%(Upper)
    Band Width0.43

    RSI (14-Day)

    Neutral
    45.4

    Momentum Oscillators

    Stoch %K71.1
    Stoch %D77.8
    Williams %R-47.1
    ROC (10d)-1.0%
    Momentum-0.15
    CCI (20d)-26.1
    MFI (14d)65.7

    Volatility Measures

    ATR (14d)$1.07(7.4%)
    StdDev (20d)1.24
    Hist Vol117.2%(High)

    Volume Flow

    VWAP$14.43
    OBV-30.5M
    AD Line-6.0M
    CMF (20d)0.131

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.6x
    VWMA (20d)$14.53

    Pivot Points

    R3$15.51
    R2$15.31
    R1$15.02
    Pivot Point$14.82
    S1$14.54
    S2$14.34
    S3$14.05

    Advanced Oscillators

    TSI-7.48
    Ultimate Osc52.5
    KST-128.05

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$630.90M$619.80M$723.60M$699.90M$613.90M$692.80M$707.80M$727.10M$637.00M$711.00M$742.60M$744.00M
    Cost of Revenue$358.00M$356.00M$403.20M$364.30M$339.00M$349.50M$381.70M$374.80M$361.00M$378.90M$361.30M$374.60M
    Gross Profit$272.90M$263.80M$320.40M$335.60M$274.90M$343.30M$326.10M$352.30M$276.00M$332.10M$381.30M$369.40M
    Operating Expenses$294.70M$291.20M$386.70M$1.04B$455.60M$310.70M$426.50M$337.30M$393.50M$2.09B$341.20M$343.10M
    R&D$48.70M$44.90M$45.80M$41.50M$45.70M$53.20M$47.30M$55.90M$56.30M$59.20M$59.30M$61.50M
    SG&A$189.70M$199.30M$194.40M$186.90M$178.00M$187.00M$181.30M$186.40M$172.50M$204.70M$172.50M$194.10M
    Operating Income$-21,800,000$-27,400,000$-66,300,000$-704,800,000$-180,700,000$32.60M$-100,400,000$15.00M$-117,500,000$-1,758,000,000$40.10M$26.30M
    Interest Income$500,000$900,000$500,000$500,000$600,000$600,000$800,000$400,000$500,000$900,000$1.40M$1.30M
    Interest Expense$54.70M$51.10M$43.10M$46.10M$46.10M$42.30M$44.70M$49.50M$47.80M$31.80M$46.20M$29.20M
    Income Before Tax$-81,200,000$-79,500,000$-112,400,000$-756,900,000$-229,600,000$-8,800,000$-140,900,000$-28,800,000$-162,900,000$-1,798,900,000$-9,200,000$-15,500,000
    Income Tax Expense$11.70M$12.30M$18.30M$-23,900,000$25.80M$3.90M$37.50M$-8,900,000$-15,200,000$-92,900,000$-16,200,000$-2,800,000
    Net Income$-92,900,000$-91,800,000$-130,700,000$-733,000,000$-255,400,000$-12,700,000$-178,400,000$-19,900,000$-147,700,000$-1,706,000,000$7.00M$-12,700,000
    EBITDA$-26,500,000$81.40M$43.20M$-597,000,000$-76,400,000$140.60M$13.10M$133.80M$1.00M$-1,637,700,000$152.40M$144.20M
    EBITN/A$-31,500,000$-69,300,000$-709,100,000$-186,700,000$33.50M$-96,200,000$20.70M$-115,100,000$-1,752,600,000$37.00M$31.10M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about QDEL

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Maintains Target Price $12

    J.P. Morgan has reiterated its Sell rating on QuidelOrtho (QDEL.US) stock, while also maintaining its target price at $12. This indicates the firm's continued bearish outlook on the company's financial performance or market position.

    Moomoo•8/25/26•
    Bearish

    Tejara Capital Ltd Takes $2.27 Million Position in QuidelOrtho Corporation $QDEL

    Tejara Capital Ltd has acquired a new stake in QuidelOrtho Corporation (NASDAQ:QDEL) worth approximately $2.27 million, representing about 0.19% of the company. Despite this investment and QuidelOrtho beating recent quarterly earnings and revenue estimates, analyst sentiment remains cautious with a consensus rating of "Reduce" and an average price target of $13.62. Other institutional investors like T. Rowe Price Investment Management Inc. and BlackRock Inc. also hold significant stakes, with institutional investors collectively owning 99% of the stock.

    MarketBeat•8/21/26•
    Neutral

    Rice Hall James & Associates LLC Invests $18.63 Million in QuidelOrtho Corporation $QDEL

    Rice Hall James & Associates LLC has acquired a new stake in QuidelOrtho Corporation (NASDAQ:QDEL) worth approximately $18.63 million, representing 1.56% of the company. Other institutional investors have also adjusted their holdings in QuidelOrtho, with institutional ownership nearing 99%. Despite beating earnings expectations, the company faces a "Reduce" consensus rating from analysts, with a target price below its opening stock price.

    MarketBeat•8/18/26•
    Neutral

    QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed

    QuidelOrtho (QDEL) saw its stock rise by 6.0% despite cutting its 2026 revenue guidance to US$2.52–2.60 billion from US$2.70–2.75 billion. The company reported narrower losses in Q2 2026, with sales of US$630.9 million, but faces ongoing challenges including persistent losses and a tight cash position. The new CFO, Micah Young, will oversee cost control and portfolio decisions as investors monitor the company's path to profitability by 2029.

    Yahoo Finance•8/17/26•
    Somewhat-Bearish

    QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?

    QuidelOrtho (QDEL) has seen its stock rally 31.7% in three months due to resilient core diagnostics growth and cost-saving initiatives. However, the company faces headwinds from a sharp slowdown in China, weakening respiratory demand, and a cut in its 2026 revenue and earnings guidance, along with a heavily leveraged balance sheet. The stock currently holds a Zacks Rank #5 (Strong Sell), indicating potential challenges in sustaining its recent gains.

    TradingView•8/17/26•
    Somewhat-Bearish

    Frequently Asked Questions About QDEL

    Does QDEL pay dividends?
    Quidel Corporation (QDEL) does not currently pay a regular dividend.
    What is QDEL's P/E ratio?
    Quidel Corporation has a price-to-earnings (P/E) ratio of 10.69.
    What is QDEL's market cap?
    Quidel Corporation (QDEL) has a market capitalization of $1.01B with a current stock price of $14.43.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In